Skip to main content
Log in

Serum calcium and the risk of prostate cancer

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Background

Recent studies have suggested an association between high dietary intake of calcium and the risk of prostate cancer. Calcium-rich diet has been suggested to affect the serum levels of Vitamin D, and thereby promote cancer. We conducted the largest study of the association between prediagnostic serum levels of calcium and the risk of prostate cancer.

Outline

We examined the incidence of prostate cancer in relation to prediagnostic serum calcium levels in a prospective cohort study of 22,391 healthy Swedish men, of which 1,539 incident cases of prostate cancer were diagnosed during the 30 years of follow-up until December 2006.

Material and methods

Serum levels of calcium were measured at baseline, and categorized into quartiles. Cox regression was used to estimate the adjusted hazard ratios (HR) with 95% confidence intervals (CI).

Results

We found no evidence of an association between prediagnostic serum levels of calcium and risk of prostate cancer (HR for trend = 0.99 [95% CI;0.94–1.03]). However, a moderate significant negative association was seen in men with a BMI above 25 and aged below 45 years at baseline (Highest vs. lowest quartile, HR = 0.63 [95% CI;0.40–0.99]).

Conclusion

These data do not support the hypothesis that high serum calcium levels is a risk factor for prostate cancer. On the contrary, the data suggest that high serum levels of calcium in young overweight men may be a marker for a decreased risk of developing prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grönberg H (2003) Prostate cancer epidemiology. Lancet 361: 859–864

    Article  PubMed  Google Scholar 

  2. Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL (2001) Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr 74:549–554

    PubMed  CAS  Google Scholar 

  3. Tseng M, Breslow RA, Graubard BI, Ziegler RG (2005) Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr 81:1147–1154

    PubMed  CAS  Google Scholar 

  4. Giovannucci E, Liu Y, Stampfer MJ, Willett WC (2006) A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 15:203–210

    Article  PubMed  CAS  Google Scholar 

  5. Kesse E, Bertrais S, Astorg P, Jaouen A, Arnault N, Galan P et al (2006) Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplémentation en Vitamines et Minéraux Antioxydants) study. Br J Nutr 95:539–545

    Article  PubMed  CAS  Google Scholar 

  6. Gao X, LaValley MP, Tucker KL (2005) Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 97:1768–1777

    Article  PubMed  CAS  Google Scholar 

  7. Giovannucci E (1998) Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 9:567–582

    Article  PubMed  CAS  Google Scholar 

  8. Schwartz GG, Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10:1307–1311

    PubMed  CAS  Google Scholar 

  9. Skinner HG, Schwartz GG (2008) Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 17:2302–2305

    Article  PubMed  CAS  Google Scholar 

  10. Skinner HG, Schwartz GG (2009) A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 18:575–578

    Article  PubMed  CAS  Google Scholar 

  11. Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M et al (2007) Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16:2623–2630

    Article  PubMed  CAS  Google Scholar 

  12. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 64:729–736

    Article  PubMed  CAS  Google Scholar 

  13. Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519–1524

    Article  PubMed  CAS  Google Scholar 

  14. Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, Mandel JS et al (2005) Risk of prostate cancer in a randomized clinical trial of calcium supplementation. Cancer Epidemiol Biomarkers Prev 14:586–589

    Article  PubMed  CAS  Google Scholar 

  15. Bonjour JP, Chevalley T, Fardellone P (2007) Calcium intake and vitamin D metabolism and action, in healthy conditions and in prostate cancer. Br J Nutr 97:611–616

    Article  PubMed  CAS  Google Scholar 

  16. Gann PH, Ma J, Hennekens CH, Hollis BW, Haddad JG, Stampfer MJ (1996) Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev 5:121–126

    PubMed  CAS  Google Scholar 

  17. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11:847–852

    Article  PubMed  CAS  Google Scholar 

  18. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case–control study in the Nordic countries. Int J Cancer 108:104–108

    Article  PubMed  CAS  Google Scholar 

  19. Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA (2007) Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev 16:2784–2786

    Article  PubMed  CAS  Google Scholar 

  20. Jacobs ET, Giuliano AR, Martńnez ME, Hollis BW, Reid ME, Marshall JR (2004) Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 89–90:533–537

    Google Scholar 

  21. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15:255–265

    Article  PubMed  Google Scholar 

  22. Almquist M, Manjer J, Bondeson L, Bondeson AG (2007) Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women. Cancer Causes Control 18:595–602

    Article  PubMed  Google Scholar 

  23. Berglund G, Eriksson KF, Israelsson B, Kjellström T, Lindgärde F, Mattiasson I et al (1996) Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 239:489–497 (MPP Malmö Preventive Project)

    Google Scholar 

  24. Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:1653–1658

    PubMed  CAS  Google Scholar 

  25. Kristenson H, Trell E (1982) Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 77:297–304

    Article  PubMed  CAS  Google Scholar 

  26. Lindkvist B, Appelros S, Manjer J, Berglund G, Borgstrom A (2008) A prospective cohort study of smoking in acute pancreatitis. Pancreatology 8:63–70

    Article  PubMed  Google Scholar 

  27. Subset of FOB80 from Statistics Sweden. Statistiska Centralbyrån SCB, Örebro, Sweden, http://www.scb.se

  28. Barlow L, Westergren K, Holmberg L, Talbäck M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48:27–33

    Article  PubMed  Google Scholar 

  29. SPSS Version 15.0. SPSS Inc. headquarters, 233 S. Wacker Drive, 11th floor, Chicago, IL 60606

  30. SPSS Version 16.0. SPSS Inc. headquarters, 233 S. Wacker Drive, 11th floor, Chicago, IL 60606

  31. Bischof MG, Heinze G, Vierhapper H (2006) Vitamin D status and its relation to age and body mass index. Horm Res 66:211–215

    Article  PubMed  CAS  Google Scholar 

  32. Prins GS, Korach KS (2008) The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73(3): 233–244

    Article  PubMed  CAS  Google Scholar 

  33. Falahati-Nini A, Riggs BL, Atkinson EJ, O’Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553–1560

    Article  PubMed  CAS  Google Scholar 

  34. Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B et al (2007) Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 99:1881–1887

    Article  PubMed  Google Scholar 

  35. Onkologiskt Centrum Syd (Oncological Center Sothern Sweden) (2009) http://www.ocsyd.se/VP-verksamhet/index_vardprogr.html

  36. OCSyd (2004) Prostatacancer Regional rapport. Technical report, Onkologiskt Centrum Syd, Sweden

  37. OCsyd (2006) Prostatacancer Regional rapport. Technical report, Onkologiskt Centrum Syd, Sweden

  38. Nilsson-Ehle P (2003) Laurells klinisk kemi i praktisk medicin. Studentlitteratur AB, Sweden

  39. Almquist M, Bondeson AG, Bondeson L, Halthur C, Malm J, Manjer J (2008) Reproductive history, lifestyle factors and season as determinants for serum calcium concentrations in women. Scand J Clin Lab Invest 68:777–785

    Article  PubMed  CAS  Google Scholar 

  40. Leifsson BG, Ahrén B (1996) Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 81:2149–2153

    Article  PubMed  CAS  Google Scholar 

  41. Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H et al (2000) Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med 247:19–29

    Article  PubMed  CAS  Google Scholar 

  42. Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132:2208–2225

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Halthur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halthur, C., Johansson, A.L.V., Almquist, M. et al. Serum calcium and the risk of prostate cancer. Cancer Causes Control 20, 1205–1214 (2009). https://doi.org/10.1007/s10552-009-9342-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-009-9342-y

Keywords

Navigation